You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 136 No. 8, August 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial Review
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on ISI (7)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Diagnosis
 •Dermatologic Disorders, Other
 •Alert me on articles by topic

Questions Answered and a $1 Million Question Raised Concerning Lupus Erythematosus Tumidus

Is Routine Laboratory Surveillance Testing During Treatment With Hydroxychloroquine for Skin Disease Really Necessary?

Richard D. Sontheimer, MD

Arch Dermatol. 2000;136:1044-1049.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

INTRODUCTION

After a professional lifetime of studying the cutaneous manifestations of lupus erythematosus (LE), I have found LE tumidus (LET) (also referred to, perhaps incorrectly, as lupus tumidus and tumid LE by modern dermatologists) to be the most enigmatic form of cutaneous LE (CLE). The clinical and pathogenetic significance of LET has until very recently been ignored completely in the medical literature published in English. While preparing comprehensive reviews of LE-specific skin disease in the past,1 virtually no published literature on this form of CLE in English could be found in the MEDLINE database. When performing a text word search of the term lupus tumidus in MEDLINE, one comes up as often with case descriptions of cutaneous tuberculosis2 as CLE. However, Kuhn and coworkers3 from the Department of Dermatology at Heinrich-Heine-University in Düsseldorf, Germany, have begun to illuminate the nature and significance of this form of CLE . . . [Full Text of this Article]

A MODERN VIEW OF LET

THREE CHEERS FOR OUR INTERNATIONAL COLLEAGUES IN MEDICAL DERMATOLOGY

LAGNIAPPE

Is There a Need for Routine Laboratory Surveillance During Treatment With Hydroxychloroquine and Other Aminoquinoline Antimalarials?

The Need for a Multicenter Mechanism to Promote Systematic Patient-Oriented Research in Orphan Dermatological Diseases

From the Department of Dermatology, The University of Iowa College of Medicine/The University of Iowa Health Care, Iowa City.


RELATED ARTICLE

Lupus Erythematosus Tumidus: A Neglected Subset of Cutaneous Lupus Erythematosus: Report of 40 Cases
Annegret Kuhn, Dagmar Richter-Hintz, Claudia Oslislo, Thomas Ruzicka, Mosaad Megahed, and Percy Lehmann
Arch Dermatol. 2000;136(8):1033-1041.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

LET Us Remember
Journal Watch Dermatology 2000;2000:6-6.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.